Atlas Trials

The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer

Clinical trial NCT00345059 · TERMINATED

Trial details

NCT number
NCT00345059
Sponsor
National Cancer Institute, Naples
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Non-Small Cell Lung Cancer
Start date
2005-05-01
Primary completion
2008-05-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.